MONOPAR THERAPEUTICS INC (MNPR) Stock Analyst Ratings
NASDAQ:MNPR - Nasdaq - US61023L2079 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to MNPR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 27.88. This target is -12% below the current price.
MNPR was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MNPR.
In the previous month the buy percentage consensus was at a similar level.
MNPR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-10 | Piper Sandler | Initiate | Overweight |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-11 | Rodman & Renshaw | Initiate | Buy |
| 2024-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-11 | JonesTrading | Upgrade | Hold -> Buy |
| 2023-06-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-03-29 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-03-28 | EF Hutton | Maintains | Buy |
| 2023-03-24 | EF Hutton | Reiterate | Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-14 | EF Hutton | Reiterate | Buy |
| 2023-01-23 | EF Hutton | Initiate | Buy |
| 2022-12-09 | Roth Capital | Reiterate | Buy |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-01 | HC Wainwright & Co. | Initiate | Buy |